Abstract
Sotorasib, a direct inhibitor of the enzyme Kirsten rat sarcoma viral oncogene (KRAS) with the G12C mutation, was approved by the U.S. Food and Drug A......
小提示:本篇文献需要登录阅读全文,点击跳转登录